CONNECT WITH US
Tech

Tech

Anthropic's Dario Amodei uses IPO pitch to promise AI will eliminate cancer and Alzheimer's within a decade

TechSpot logo

Published on

Add as a preferred source on Google
Anthropic's Dario Amodei uses IPO pitch to promise AI will eliminate cancer and Alzheimer's within a decade

Facepalm: AI still hasn't cured cancer, or any disease, for that matter. Don't worry, though, because Anthropic boss Dario Amodei has assured us that the technology will not only eliminate this disease but also Alzheimer's, heart disease, and mental illness in a decade. The fact that this bold and heavily mocked statement came as part of his IPO pitch is absolutely unrelated, because who among us wouldn't want to invest in a company that is going to "create an age of miracles?"

Amodei made his latest wild prediction during an IPO roadshow video the company released yesterday. It's around 42 minutes long, but the part receiving the most attention is his ambitious plan for the future of medicine.

"You know, if today we look at things like cancer, Alzheimer's, heart disease, mental illness, these will be relics of the past in, I think, less than a decade."

If that wasn't enough to emphasize the godlike power of AI, Amodei added that the technology, presumably Anthropic's, will catapult us into a utopia where illness vanishes.

"I think if we do this right, we can create an age of miracles where humanity is able to solve problems that have eluded us for millennia," he gushed.

The CEO obviously had to include something about where his own AI giant fits into all this. "And I believe that the company which gets the risks right will also be the company that has the license to operate that society trusts and society believes can build the benefits in the right way," he said.


Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.